Nicotine Oral Dissolvable Thin Films Market
完整報告名稱與涵蓋範圍
Nicotine Oral Dissolvable Thin Films Market Research Report Information by Strength (1mg, 2mg, and Others), by Route of Administration (Tongue and Buccal), and by Age Group (Adults and Adolescents), by Sales Channel (Online and Offline), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032
報告摘要
Nicotine Oral Dissolvable Thin Films Market Research Report Information by Strength (1mg, 2mg, and Others), by Route of Administration (Tongue and Buccal), and by Age Group (Adults and Adolescents), by Sales Channel (Online and Offline), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032
Overview of the Market
In 2023, the market for nicotine oral dissolvable thin films was estimated to be worth USD 0.10 billion. With a compound annual growth rate (CAGR) of 3.86% from 2024 to 2032, the market for nicotine oral dissolveable thin films is expected to increase from USD 0.11 billion in 2024 to USD 0.15 billion by 2032.
Increased efforts to stop smoking are driving a significant demand for nicotine oral dissolvable thin films, which is accelerating market expansion in a number of ways. Public health campaigns and government initiatives, such those run by the Office on Smoking and Health (OSH), are actively urging people to quit smoking or reduce their nicotine intake. Programs designed to reduce tobacco use support these efforts by providing resources and skills for implementing effective quitting techniques.
Moreover, the worldwide market for nicotine oral dissolvable thin films is mostly driven by the advantages of oral thin film (OTF) technology. A few of the main advantages that support market expansion are listed below. OTFs are a handy and portable way to give nicotine because they dissolve quickly in the mouth and don't require water. They are available for users to use quietly from anywhere at any time.
Perspectives on Market Segments
The market for nicotine oral dissolvable thin films has been divided into segments based on strength, including 1 mg and 2 mg.
The market has been divided into tongue and buccal segments based on the administration route.
The market for nicotine oral dissolvable thin films has been divided into two segments based on age: adults and adolescents.
The market has been divided into online and offline segments based on the sales channel.
Geographic Perspectives
The market for nicotine oral dissolvable thin films in North America was valued at USD 31.20 million in 2023 and is anticipated to expand at a compound annual growth rate (CAGR) of 3.86% over the course of the forecast period. The United States and Canada are two more divisions of North America. The growing frequency of smoking-related health problems and growing awareness of smoking cessation aids are driving the market for nicotine oral dissolvable thin films in North America.
The market for nicotine oral dissolvable films in Europe was valued at USD 44.48 million in 2023 and is anticipated to expand at a compound annual growth rate (CAGR) of 3.46% over the course of the forecast period. The market for nicotine oral dissolvable thin films in Europe is expected to increase significantly over the next several years because to the growing demand for these products and the presence of competitors.
The market for nicotine oral dissolvable films in the Asia-Pacific region was valued at USD 20.74 million in 2023 and is anticipated to expand at a compound annual growth rate (CAGR) of 4.77% over the course of the forecast period. Because of rising health consciousness, urbanization, and the high prevalence of smoking in nations like China, South Korea, India, and Japan, the market for nicotine oral dissolvable thin films in the Asia-Pacific region is expanding significantly.
Key Players
Nicoccino Holding AB (Japan), AdhexPharma (France), ARx, LLC (US), ZIM Laboratories Limited (India), LTS Lohmann Therapie-Systeme AG (Germany), NAL Pharma (China), INVENTZ Lifesciences (India), Renejix Pharma Solutions (US), and DK Livkon Healthcare Pvt. Ltd. (India) are important players in the nicotine oral dissolvable thin film market.
授權報價
| Single User Price | $4,950 USD |
| Multi User Licence (up to 10 users) | $5,950 USD |
| Enterprisewide Price (Global Site License) | $7,250 USD |
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
3.5.1 PRIMARY RESEARCH DATA FLOW:
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
3.8.1 MICROECONOMIC FACTOR ANALYSIS:
3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 INCREASING SMOKING AND TOBACCO CESSATION EFFORTS
4.2.2 ADVANTAGE OF ORAL THIN FILM DRIVES THE MARKET GROWTH
4.3 RESTRAINTS
4.3.1 STRINGENT REGULATORY POLICIES
4.3.2 PRESENCE OF NICOTINE REPLACEMENT THERAPIES
4.3.3 PATENT PROTECTION OF NICOTINE ORAL THIN FILM PRODUCTS
4.4 OPPORTUNITY
4.4.1 INITIATION TO BUILD AND LAUNCH ORAL THIN FILM MANUFACTURING
4.4.2 INNOVATION ASSOCIATED WITH NICOTINE ORAL THIN FILM
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET
5.4 QUALITATIVE INFORMATION ON PACKAGING OF NICOTINE ORAL DISSOLVABLE THIN FILMS
5.4.1 PACKAGING MATERIALS
5.4.1.1 FOIL, PAPER, OR PLASTIC POUCHES
5.4.1.2 SINGLE POUCH AND ALUMINUM POUCH
5.4.1.3 BLISTER CARD WITH MULTIPLE UNITS
5.4.1.4 BARRIER FILMS
5.4.2 LABELING AND INFORMATION FOR NICOTINE ORAL DISSOLVABLE THIN FILMS
5.4.2.1 REGULATORY COMPLIANCE
5.4.2.2 NICOTINE DOSAGE
5.4.2.3 WARNINGS AND PRECAUTIONS
5.4.2.4 EXPIRATION DATES
5.5 QUALITATIVE INFORMATION ON END USE OF NICOTINE ORAL DISSOLVABLE THIN FILMS
5.5.1 CHALLENGES IN FORMULATION, STABILITY, AND MANUFACTURING OF ORAL THIN FILM (OTF)
5.5.2 STRINGENT REGULATORY POLICIES FOR THE GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILM MARKET
5.6 QUALITATIVE INFORMATION ON END USE OF NICOTINE ORAL DISSOLVABLE THIN FILMS
5.6.1 SMOKERS & EX-SMOKERS
5.6.2 CONVENIENCE AND DISCREET USE
5.7 PRICING ANALYSIS, BY REGION 2023 (USD)
6 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH
6.1 OVERVIEW
6.2 1MG
6.3 2MG
6.4 OTHERS
7 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION
7.1 OVERVIEW
7.2 TONGUE
7.3 BUCCAL
8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP
8.1 OVERVIEW
8.2 ADULTS
8.3 ADOLESCENTS
9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL
9.1 OVERVIEW
9.2 ONLINE
9.3 OFFLINE
10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 SOUTH KOREA
10.4.5 AUSTRALIA
10.4.6 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 LATIN AMERICA
10.5.2 MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS, 2023
11.3 COMPETITOR DASHBOARD
11.4 PUBLIC PLAYERS STOCK SUMMARY
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 AGREEMENT
11.6.2 EXPANSION
11.6.3 PRODUCT APPROVAL
11.6.4 PRODUCT RECOGNITION
12 COMPANY PROFILES
12.1 NICOCCINO HOLDING AB
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS OFFERED
12.1.4 ADDITIONAL INFORMATION
12.1.5 KEY DEVELOPMENTS
12.1.6 SWOT ANALYSIS
12.1.7 KEY STRATEGIES
12.2 NISSHA CO., LTD.
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS OFFERED
12.2.4 ADDITIONAL INFORMATION
12.2.5 KEY DEVELOPMENTS
12.2.6 SWOT ANALYSIS
12.2.7 KEY STRATEGIES
12.3 ADHEXPHARMA
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCT OFFERED
12.3.4 ADDITIONAL INFORMATION
12.3.5 KEY DEVELOPMENTS
12.3.6 KEY STRATEGIES
12.4 ARX, LLC
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 ADDITIONAL INFORMATION
12.4.5 KEY DEVELOPMENTS
12.4.6 KEY STRATEGIES
12.5 ZIM LABORATORIES LIMITED
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 ADDITIONAL INFORMATION
12.5.5 KEY DEVELOPMENTS
12.5.6 SWOT ANALYSIS
12.5.7 KEY STRATEGIES
12.6 LTS LOHMANN THERAPIE-SYSTEME AG
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS OFFERED
12.6.4 ADDITIONAL INFORMATION
12.6.5 KEY DEVELOPMENTS
12.6.6 SWOT ANALYSIS
12.6.7 KEY STRATEGIES
12.7 NAL PHARMA
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 ADDITIONAL INFORMATION
12.7.5 KEY DEVELOPMENTS
12.7.6 KEY STRATEGIES
12.8 INVENTZ
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 ADDITIONAL INFORMATION
12.8.5 KEY DEVELOPMENTS
12.8.6 SWOT ANALYSIS
12.8.7 KEY STRATEGIES
12.9 RENEJIX PHARMA SOLUTIONS
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 SERVICES OFFERED
12.9.4 ADDITIONAL INFORMATION
12.9.5 KEY DEVELOPMENTS
12.9.6 KEY STRATEGIES
12.10 DK LIVKON PVT. LTD
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 SERVICES OFFERED
12.10.4 ADDITIONAL INFORMATION
12.10.5 KEY DEVELOPMENTS
12.10.6 KEY STRATEGIES
13 DATA CITATIONS
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 ADVANTAGE OF ORAL THIN FILM
TABLE 3 PATENT PROTECTION OF NICOTINE ORAL THIN FILM PRODUCTS
TABLE 4 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 5 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR 1MG, BY REGION, 2019–2032 (USD MILLION)
TABLE 6 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR 2MG, BY REGION, 2019–2032 (USD MILLION)
TABLE 7 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR TONGUE, BY REGION, 2019–2032 (USD MILLION)
TABLE 10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR BUCCAL, BY REGION, 2019–2032 (USD MILLION)
TABLE 11 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 12 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ADULTS, BY REGION, 2019–2032 (USD MILLION)
TABLE 13 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ADOLESCENTS, BY REGION, 2019–2032 (USD MILLION)
TABLE 14 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 15 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ONLINE, BY REGION, 2019–2032 (USD MILLION)
TABLE 16 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR OFFLINE, BY REGION, 2019–2032 (USD MILLION)
TABLE 17 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2019–2032 (USD MILLION)
TABLE 18 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 19 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 20 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 21 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 22 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 23 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 24 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 25 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 26 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 27 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 28 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 29 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 30 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 31 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 1 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 2 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 3 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 4 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 5 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 6 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 7 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 8 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 9 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 10 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 11 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 12 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 13 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 14 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 15 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 16 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 17 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 18 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 19 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 20 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 21 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 22 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 23 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 24 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 25 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 26 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 27 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 28 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 29 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 1 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 2 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 3 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 4 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 5 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 6 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 7 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 8 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 9 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 10 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 11 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 12 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 13 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 14 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 15 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 16 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 17 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 18 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 19 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 20 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 21 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 22 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 23 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 24 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 1 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 2 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 3 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 4 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 5 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2019–2032 (USD MILLION)
TABLE 1 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 2 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 3 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 4 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 5 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 6 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 7 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 8 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)
TABLE 13 PUBLIC PLAYERS STOCK SUMMARY
TABLE 14 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 15 AGREEMEENT
TABLE 16 EXPANSION
TABLE 17 PRODUCT APPROVAL
TABLE 18 PRODUCT RECOGNITION
TABLE 19 NICOCCINO HOLDING AB: PRODUCTS OFFERED
TABLE 20 NICOCCINO HOLDING AB: ADDITIONAL INFORMATION
TABLE 21 NISSHA CO., LTD.: PRODUCTS OFFERED
TABLE 22 NISSHA CO., LTD.: ADDITIONAL INFORMATION
TABLE 23 ADHEXPHARMA: PRODUCTS OFFERED
TABLE 24 ADHEXPHARMA: ADDITIONAL INFORMATION
TABLE 25 ARX, LLC: PRODUCTS OFFERED
TABLE 26 ARX, LLC: ADDITIONAL INFORMATION
TABLE 27 ZIM LABORATORIES LIMITED: PRODUCTS OFFERED
TABLE 28 ZIM LABORATORIES LIMITED: ADDITIONAL INFORMATION
TABLE 29 ZIM LABORATORIES LIMITED: KEY DEVELOPMENTS
TABLE 30 LTS LOHMANN THERAPIE-SYSTEME AG: PRODUCTS OFFERED
TABLE 31 LTS LOHMANN THERAPIE-SYSTEME AG: ADDITIONAL INFORMATION
TABLE 32 NAL PHARMA: PRODUCTS OFFERED
TABLE 33 ADDITIONAL INFORMATION
TABLE 34 INVENTZ: PRODUCTS OFFERED
TABLE 35 INVENTZ: ADDITIONAL INFORMATION
TABLE 36 RENEJIX PHARMA SOLUTIONS: SERVICES OFFERED
TABLE 37 RENEJIX PHARMA SOLUTIONS: ADDITIONAL INFORMATION
TABLE 38 DK LIVKON PVT. LTD: SERVICES OFFERED
TABLE 39 DK LIVKON PVT. LTD: ADDITIONAL INFORMATION
LIST OF FIGURES
FIGURE 1 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET: STRUCTURE
FIGURE 2 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 VALUE CHAIN ANALYSIS: GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILM MARKET
FIGURE 6 MANUFACTURING PROCESS FOR THE NICOTINE ORAL DISSOLVABLE THIN FILM
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET
FIGURE 8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, STRENGTH SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2023 & 2032 (USD MILLION)
FIGURE 10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY STRENGTH, 2023
FIGURE 11 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, ROUTE OF ADMINISTRATION SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 12 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2023 & 2032 (USD MILLION)
FIGURE 13 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY ROUTE OF ADMINISTRATION, 2023
FIGURE 14 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, AGE GROUP SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 15 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2023 & 2032 (USD MILLION)
FIGURE 16 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY AGE GROUP, 2023
FIGURE 17 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, SALES CHANNEL SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 18 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2023 & 2032 (USD MILLION)
FIGURE 19 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY SALES CHANNEL, 2023
FIGURE 20 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 21 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION, 2023
FIGURE 22 NORTH AMERICA MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION)
FIGURE 23 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 24 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 25 EUROPE MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION)
FIGURE 26 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 27 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION, 2023
FIGURE 28 ASIA-PACIFIC MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2030 (USD MILLION)
FIGURE 29 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 30 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 31 REST OF THE WORLD MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION)
FIGURE 32 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 33 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION, 2023
FIGURE 34 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023
FIGURE 35 COMPETITOR DASHBOARD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET
FIGURE 36 NICOCCINO HOLDING AB: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 NICOCCINO HOLDING AB: SWOT ANALYSIS
FIGURE 38 NISSHA CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 NISSHA CO., LTD.: SWOT ANALYSIS
FIGURE 40 ZIM LABORATORIES LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 ZIM LABORATORIES LIMITED: SWOT ANALYSIS
FIGURE 42 LTS LOHMANN THERAPIE-SYSTEME AG: SWOT ANALYSIS
FIGURE 43 INVENTZ: SWOT ANALYSIS
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們